Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Buelent Polat"'
Autor:
Tanja Grimmig, Martin Gasser, Romana Moench, Lang-Jing Zhu, Karol Nawalaniec, Simone Callies, Martin Wagner, Buelent Polat, Suraj Sarvode Mothi, Yueming Luo, Carmen M. Ribas, Osvaldo Malafaia, Li-Li Hsiao, Ana Maria Waaga-Gasser
Publikováno v:
OncoImmunology, Vol 8, Iss 12 (2019)
CD137-targeting immune therapy, which activates anti-tumor T effector cell responses, seems to be an attractive concept in clinical oncology. Recent evidence has demonstrated that tumor cells besides T cells and antigen-presenting cells are able to e
Externí odkaz:
https://doaj.org/article/0324c382a4fd4bea8c614b3e78e00d09
Autor:
C. Muench, Michael Flentje, Buelent Polat, Kevin Klann, Elena Gerhard-Hartmann, Christina Schülein-Völk, Markus E. Diefenbacher, Thomas Fischer, Oliver Hartmann, Mathias T. Rosenfeldt, Cristian Prieto-Garcia, Apoorva Baluapuri, Michaela Reissland
BackgroundDespite advances in treatment of patients with non-small cell lung cancer, carriers of certain genetic alterations are prone to failure. One such factor frequently mutated, is the tumor suppressor PTEN. These tumors are supposed to be more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f3efd5b4e25b97f14a98289c45fe04f
https://doi.org/10.21203/rs.3.rs-847293/v1
https://doi.org/10.21203/rs.3.rs-847293/v1
Autor:
Buelent Polat, T.B. Brunner, R.D. Hofheinz, Simon Kirste, Rainer Fietkau, Thomas Kuhnt, Gunther Klautke, Christoph-Thomas Germer, Claus Rödel, E. Fokas, A. Schlenska-Lange, T. Friede, Michael Ghadimi, W.O. Bechstein, A.L. Grosu, Michael Flentje
Publikováno v:
Radiotherapy and Oncology. 161:S199-S200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79d53d545a5c3cd73b51020252bcaf9
https://doi.org/10.1016/s0167-8140(21)06841-9
https://doi.org/10.1016/s0167-8140(21)06841-9
Publikováno v:
Radiotherapy and Oncology. 161:S1561
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eed6e94f161b8dd36a68d773c2404a01
https://doi.org/10.1016/s0167-8140(21)08282-7
https://doi.org/10.1016/s0167-8140(21)08282-7
Autor:
Martin Gasser, Tanja Grimmig, Ana Maria Waaga-Gasser, Li-Li Hsiao, Suraj Sarvode Mothi, Yueming Luo, Carmen Australia Paredes Marcondes Ribas, Martin Wagner, Osvaldo Malafaia, Lang-Jing Zhu, Simone Callies, Karol Nawalaniec, Buelent Polat, Romana Moench
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 8, Iss 12 (2019)
OncoImmunology, Vol 8, Iss 12 (2019)
CD137-targeting immune therapy, which activates anti-tumor T effector cell responses, seems to be an attractive concept in clinical oncology. Recent evidence has demonstrated that tumor cells besides T cells and antigen-presenting cells are able to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6b645803498db084f33079618be1d8
http://europepmc.org/articles/PMC6844327
http://europepmc.org/articles/PMC6844327
Publikováno v:
Radiotherapy and Oncology. 133:S790-S791
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b080f645ffa801d0f1d9f7e5c7f8b9b1
https://doi.org/10.1016/s0167-8140(19)31878-x
https://doi.org/10.1016/s0167-8140(19)31878-x
Autor:
Buelent Polat, Arnd Honig, Peter Kranke, Jens C. Hahne, Susanne R. Meyer, Johannes Dietl, Matthias Guckenberger
Publikováno v:
Strahlentherapie und Onkologie. 189:1040-1048
Osteopontin-1 is a well characterized protein in many tumour entities. Multiple roles in the processes invasion, metastasis and angiogenesis of tumours are attributed to osteopontin-1. The putative role of osteopontin-1 has not been characterized for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36d3b61e0cf4850e6dc3515dc08dda1f
https://doi.org/10.1007/s00066-013-0434-y
https://doi.org/10.1007/s00066-013-0434-y
Autor:
Tanja Grimmig, Buelent Polat, Martin Wagner, Ana Maria Waaga-Gasser, Simone Callies, Romana Moench, Hannes Naegele, Christoph-Thomas Germer, Martin Gasser
Publikováno v:
Cancer Research. 77:5616-5616
Background: CD137L is expressed on antigen presenting cells and CD137/CD137L interaction co-stimulates activation and proliferation of CD137 expressing T cells. CD137L expression has also been detected on various cancer cells. While signaling in immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf17b74480c26e4dfc0916e6dde0591b
https://doi.org/10.1158/1538-7445.am2017-5616
https://doi.org/10.1158/1538-7445.am2017-5616
Autor:
A. Technau, Cholpon S. Djuzenova, Michael Flentje, Gisela Wohlleben, Buelent Polat, Astrid Katzer
Publikováno v:
Strahlentherapie und Onkologie. 189:62-67
Osteopontin (OPN) is a multifunctional protein overexpressed in many cancers and is involved in tumor progression and metastasis. In lung cancer, elevated OPN expression is associated with an unfavorable prognosis. Therefore, inhibition of OPN is an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbe929537d82cd9f5cd6fcb9f84f31f
https://doi.org/10.1007/s00066-012-0238-5
https://doi.org/10.1007/s00066-012-0238-5
Autor:
Michael Flentje, Claudiu T. Supuran, Buelent Polat, Adrian Staab, Jelena Anacker, Andrea Scozzafava, Dirk Vordermark, Carsten Hageman, Harun M. Said, Astrid Katzer
Publikováno v:
Current Pharmaceutical Design. 16:3288-3299
Hypoxia is a crucial factor in tumour aggressiveness and its treatment resistance, particularly in human brain cancer. Tumour resistance against radiation- and chemo- therapy is facilitated by oxygenation reduction at tumour areas. HIF-1α regulated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4555013bfbb9a0d03f6cdbac62aa1c7
https://doi.org/10.2174/138161210793429788
https://doi.org/10.2174/138161210793429788